Signal active
Contact Information
Social
Primary Organization
2014
51-100
Biotechnology, Therapeutics, Clinical Trials
Bio
Michael G. King Jr is the current Chief Financial Officer of SAB Biotherapeutics. He previously worked at EF Hutton as a Managing Director and Head of Healthcare Research. Michael G. King Jr attended Baruch College.
Location
Sioux Falls, South Dakota, United States, North America
Jobs history
2
RexBioMed
President & CEO
2009 - 2023
SAB Biotherapeutics
Chief Financial Officer
2023 - 2024
Board and Advisor Roles
1
SAB Biotherapeutics
Advisor
2024 - Current
Educations
1
N/A
Profile Resume
Michael G. King Jr is the Chief Financial Officer at SAB Biotherapeutics, based in United States, North America. With a background in Biotechnology, Michael G. King Jr has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity